Index Rebal Trades & Special Situations, Quiddity Advisors

Janaghan Jeyakumar, CFA

Index Rebal Trades & Special Situations

Quiddity Advisors

Pan-Asia Catalysts/Events

Index Rebalance

<ul>
<li>The SE600 index is one of the most widely followed benchmark indices in Europe. This index is rebalanced on a quarterly basis.</li>
<li>In this insight, we take a look at the potential index changes that could take place between now and the end of the December 2023 rebalance.</li>
<li>This includes a couple of intra-review index changes that could be triggered by the <a href="https://www.smartkarma.com/entities/dechra-pharmaceuticals-plc" target="_blank" data-smartkarma-citation="entities:21908:1" rel="noopener">Dechra Pharmaceuticals (DPH LN)</a> and <a href="https://www.smartkarma.com/entities/chr-hansen-holding-a-s" target="_blank" data-smartkarma-citation="entities:22322:1" rel="noopener">Chr Hansen Holding A/S (CHR DC)</a> takeover situations.</li>
</ul>


The SE600 index is one of the most widely followed benchmark indices in Europe. This index is rebalanced on a quarterly basis.
In this insight, we take a look at the potential index changes that could take place between now and the end of the December 2023 rebalance.
This includes a couple of intra-review index changes that could be triggered by the Dechra Pharmaceuticals (DPH LN) and Chr Hansen Holding A/S (CHR DC) takeover situations.


Quiddity Leaderboard SE600 Dec 23: Novartis-Sandoz, Dechra, CHR, and Others

Santander Bank Polska SA / Index Rebalance

<ul>
<li>In this insight, we take a look at the names leading the race to become ADDs/DELs for the STX Europe 600 and EUROSTX Indices for the March 2023 Rebalance.</li>
<li>There is roughly one more month left to the base date. At present, I see around 3 ADDs/DELs in the June 2023 review.</li>
<li>Separately, STX Europe 600 members <a href="https://www.smartkarma.com/entities/credit-suisse-group-ag-f4b24f0c-c294-40b3-b491-759f0cb277e9" target="_blank" data-smartkarma-citation="entities:27915:1" rel="noopener">Credit Suisse (CSGN SW)</a> and <a href="https://www.smartkarma.com/entities/vantage-towers-ag" target="_blank" data-smartkarma-citation="entities:35602:1" rel="noopener">Vantage Towers (VTWR GR)</a> could possibly get deleted in the next few months triggering intra-review index changes.</li>
</ul>


In this insight, we take a look at the names leading the race to become ADDs/DELs for the STX Europe 600 and EUROSTX Indices for the March 2023 Rebalance.
There is roughly one more month left to the base date. At present, I see around 3 ADDs/DELs in the June 2023 review.
Separately, STX Europe 600 members Credit Suisse (CSGN SW) and Vantage Towers (VTWR GR) could possibly get deleted in the next few months triggering intra-review index changes.


Quiddity Leaderboard SE600 Jun 23: Three ADDs/DELs Likely

Leading Independent Investment Research, Morningstar, Inc.

Morningstar

Leading Independent Investment Research

Morningstar, Inc.

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. We offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors. 

Morningstar provides data on more than 500,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 16 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries, with more than $180 billion in assets under advisement or management as of June 30, 2015. We have operations in 27 countries.

Download the Morningstar Fact Sheet : http://corporate.morningstar.com/US/documents/MarketingFactSheets/AboutMorningstarFactsheet.pdf

Thematic (Sector/Industry)

Morningstar and PitchBook hosted the 10th annual Management Behind the Moat Conference in Chicago on Nov. 7 and 8, offering our institutional clients an opportunity to engage with the management of 49 public companies we think have structural competitive advantages, or economic moats, as well as two private companies worth watching. This report distills the highlights from company presentations. A roster of all companies that participated in the conference, including those that held one-on-one meetings with investors, can be found on Page 2 of the attached document.<figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/069/790/original/img%201.JPG?1542165661" class="editor-image img-responsive" data-smartkarma-image-id="69790"></figure>

Morningstar and PitchBook hosted the 10th annual Management Behind the Moat Conference in Chicago on Nov. 7 and 8, offering our institutional clients an opportunity to engage with the management of 49 public companies we think have structural competitive advantages, or economic moats, as well as two private companies worth watching. This report distills the highlights from company presentations. A roster of all companies that participated in the conference, including those that held one-on-one meetings with investors, can be found on Page 2 of the attached document.

Morningstar Management Behind the Moat 2018: Conference Highlights

Forensic Analyst, Trudence Capital Advisors

Nitin Mangal

Forensic Analyst

A classic case of MOAT business, Advanced Enzyme Technologies Limited <a href="https://www.smartkarma.com/entities/26960" target="_blank" data-smartkarma-citation="entities:26960:1">Advanced Enzyme Technologies (ADVENZY IN)</a> (AETL) operates in the field of enzymes. AETL hit the bourses in mid-2016 and with operating margins in the range of 40-42%, it carries the tag of a lucrative investment opportunity. The company operates globally with India and US being the highest revenue contributing geographies. A New business venture in Palm Oil in Malaysia provides AETL immense opportunity for growth.Notwithstanding this feel-good image, AETL’s public disclosures reveal certain practices that require careful attention and vetting.

A classic case of MOAT business, Advanced Enzyme Technologies Limited Advanced Enzyme Technologies (ADVENZY IN) (AETL) operates in the field of enzymes. AETL hit the bourses in mid-2016 and with operating margins in the range of 40-42%, it carries the tag of a lucrative investment opportunity. The company operates globally with India and US being the highest revenue contributing geographies. A New business venture in Palm Oil in Malaysia provides AETL immense opportunity for growth.Notwithstanding this feel-good image, AETL’s public disclosures reveal certain practices that require careful attention and vetting.

Advanced Enzyme Technologies Limited: ‘Enzyme’ Encoded With Enigma

Information Technology Consultant

Ishita Jain

Electric vehicles (“EVs”) have been around for some time now in various shapes and forms. While they have always held immense promise, mass adoption has eluded the industry. As more carmakers jump onto the bandwagon, it is worthwhile exploring the opportunities and circumstances that may finally see a trend towards mass adoption. The purpose of this insight is to shed some light on the hype around EVs, the trends in costs of EVs and investment avenues.

Electric vehicles (“EVs”) have been around for some time now in various shapes and forms. While they have always held immense promise, mass adoption has eluded the industry. As more carmakers jump onto the bandwagon, it is worthwhile exploring the opportunities and circumstances that may finally see a trend towards mass adoption. The purpose of this insight is to shed some light on the hype around EVs, the trends in costs of EVs and investment avenues.

Denmark

Novonesis (Novozymes) B operates as a bio-solutions company. The Company researches, develops, and produces industrial enzymes, microorganisms, functional proteins, and biopharmaceutical ingredients to transform consumer products and agricultural production. Novonesis (Novozymes) B serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Novonesis (Novozymes) (NSISB DC)

Quiddity Leaderboard SE600 Dec 23: Novartis-Sandoz, Dechra, CHR, and Others

I currently see six regular ADDs/DELs for the SE600 index in December 2023. Apart from that the Dechra and CHR deals could trigger two more intra...

Janaghan Jeyakumar, CFA

Quiddity Leaderboard SE600 Jun 23: Three ADDs/DELs Likely

The top 5 Potential ADDs have strong positive momentum and the top 5 potential DELs have strong negative momentum. This could continue over the...

Janaghan Jeyakumar, CFA

Morningstar Management Behind the Moat 2018: Conference Highlights

Morningstar and PitchBook hosted the 10th annual Management Behind the Moat Conference in Chicago on Nov. 7 and 8, offering our institutional...

Morningstar, Inc.

Advanced Enzyme Technologies Limited: ‘Enzyme’ Encoded With Enigma

A classic case of MOAT business, Advanced Enzyme Technologies Limited Advanced Enzyme Technologies (ADVENZY IN) (AETL) operates in the field of...

Nitin Mangal

Investing in Electric Vehicles

Electric vehicles (“EVs”) have been around for some time now in various shapes and forms. While they have always held immense promise, mass...

Ishita Jain

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)